- Home
- SAVA vs ACHR Comparison
SAVA vs ACHR Comparison
Compare SAVA & ACHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- ACHR
- Stock Information
- Founded
- SAVA 1998
- ACHR 2018
- Country
- SAVA United States
- ACHR United States
- Employees
- SAVA N/A
- ACHR N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- ACHR Aerospace
- Sector
- SAVA Health Care
- ACHR Industrials
- Exchange
- SAVA Nasdaq
- ACHR Nasdaq
- Market Cap
- SAVA 1.3B
- ACHR 1.3B
- IPO Year
- SAVA N/A
- ACHR N/A
- Fundamental
- Price
- SAVA $26.91
- ACHR $4.12
- Analyst Decision
- SAVA Strong Buy
- ACHR Buy
- Analyst Count
- SAVA 3
- ACHR 6
- Target Price
- SAVA $111.50
- ACHR $8.58
- AVG Volume (30 Days)
- SAVA 1.3M
- ACHR 20.2M
- Earning Date
- SAVA 11-07-2024
- ACHR 11-07-2024
- Dividend Yield
- SAVA N/A
- ACHR N/A
- EPS Growth
- SAVA N/A
- ACHR N/A
- EPS
- SAVA N/A
- ACHR N/A
- Revenue
- SAVA N/A
- ACHR N/A
- Revenue This Year
- SAVA N/A
- ACHR N/A
- Revenue Next Year
- SAVA N/A
- ACHR $2,048.97
- P/E Ratio
- SAVA N/A
- ACHR N/A
- Revenue Growth
- SAVA N/A
- ACHR N/A
- 52 Week Low
- SAVA $8.79
- ACHR $2.82
- 52 Week High
- SAVA $42.20
- ACHR $7.02
- Technical
- Relative Strength Index (RSI)
- SAVA 51.05
- ACHR 62.07
- Support Level
- SAVA $25.00
- ACHR $4.15
- Resistance Level
- SAVA $28.18
- ACHR $4.86
- Average True Range (ATR)
- SAVA 1.81
- ACHR 0.31
- MACD
- SAVA 0.07
- ACHR 0.10
- Stochastic Oscillator
- SAVA 62.39
- ACHR 58.15
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.